Ophthalmic AI-assisted Diagnosis Market, By Component (Software and Services), By Disease Type, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5367
|
Published Date
June 2026
|
Pages
380
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Ophthalmic AI-assisted Diagnosis Market size was valued at USD 490.2 Million in 2025, expanding to a CAGR of 21.8% from 2026 to 2033.
Ophthalmic AI-assisted diagnosis refers to the application of artificial intelligence technologies such as computer vision, machine learning, and deep learning to analyze patient data and ophthalmic images for the detection, evaluation, and monitoring of various eye disorders. These systems process outputs from diagnostic tools including fundus cameras, optical coherence tomography (OCT) devices, and retinal imaging platforms to identify abnormalities with greater speed and precision. By enabling automated image interpretation and generating clinical insights, AI-based diagnostic solutions help reduce human variability, improve diagnostic accuracy, and support earlier disease detection and intervention.
In addition, the integration of AI in ophthalmology is strengthening healthcare delivery systems by improving screening efficiency and expanding access to eye care services, particularly in regions with limited specialist availability. Governments across various countries are increasingly supporting digital health transformation programs and investing in AI-enabled medical technologies to enhance early disease detection and reduce the burden on healthcare infrastructure. For example, global health policy initiatives emphasize the need for scalable screening solutions to address rising cases of diabetic retinopathy, glaucoma, and age-related macular degeneration, all of which require continuous monitoring and early diagnosis. These developments are accelerating the adoption of AI-assisted ophthalmic diagnostic systems worldwide, improving patient outcomes and supporting more efficient clinical decision-making.
Ophthalmic AI-assisted Diagnosis Market- Market Dynamics
Rising Demand for AI-Assisted Retinal Screening, Early Disease Detection, and Advancements in Multimodal Imaging to Drive Market Growth
The rising prevalence of vision-threatening conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration is significantly driving demand for AI-enabled ophthalmic diagnostic solutions, thereby supporting the growth of the ophthalmic AI-assisted diagnosis market. Healthcare providers are increasingly adopting advanced AI models to analyze retinal images and optical coherence tomography (OCT) scans with higher speed and accuracy, enabling earlier detection and more timely clinical intervention. Recent advancements have also led to the development of autonomous diagnostic systems capable of delivering reliable assessments with minimal specialist involvement, improving the efficiency of large-scale screening programs. Furthermore, the integration of AI with cloud-based ophthalmic platforms, portable imaging devices, and teleophthalmology services is expanding access to quality eye care, particularly in remote and underserved regions. Supportive regulatory approvals, continuous improvements in digital health infrastructure, and rising investments in AI-driven healthcare technologies are further accelerating market adoption. As a result, AI-assisted ophthalmic diagnosis is becoming an integral part of modern eye care, enhancing screening efficiency, diagnostic precision, and patient outcomes.
Ongoing advancements in deep learning algorithms and ophthalmic imaging technologies are further strengthening the capabilities and clinical value of AI-assisted diagnostic systems. Modern AI platforms are now able to integrate and analyze data from multiple sources, including retinal imaging, optical coherence tomography (OCT) scans, visual field tests, and electronic health records, enabling more comprehensive and accurate disease assessment. A key emerging trend in the market is the development of multimodal AI systems that combine structural and functional ocular data to improve diagnostic accuracy and support earlier disease detection. Additionally, the incorporation of explainable AI technologies is gaining traction, offering greater transparency in how diagnostic outputs are generated. This helps ophthalmologists better understand and interpret AI-driven insights, ultimately improving clinical decision-making and trust in AI-based diagnostic tools. According to global public health data reported by organizations such as the World Health Organization (WHO), over 2.2 billion people worldwide suffer from vision impairment or blindness, a significant portion of which is preventable or treatable with early diagnosis, highlighting the importance of advanced screening and diagnostic technologies.
Ophthalmic AI-assisted Diagnosis Market- Segmentation Analysis:
The Global Ophthalmic AI-assisted Diagnosis Market is segmented on the basis of Component, Disease Type, Technology, End User, and Region.
The ophthalmic AI-assisted diagnosis market is segmented into two components: software and services. Among these, the software segment holds a significant share, primarily driven by the increasing adoption of AI-enabled diagnostic platforms capable of automatically analyzing retinal images, optical coherence tomography (OCT) scans, and other ophthalmic datasets. Healthcare institutions are increasingly implementing these solutions to strengthen screening capabilities, improve diagnostic accuracy, and enable early detection of vision-threatening conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration. The ability of AI-based software to streamline clinical workflows, reduce diagnostic variability, and deliver fast, data-driven insights is further accelerating segment growth. According to global public health estimates from organizations such as the World Health Organization (WHO), over 2.2 billion people worldwide suffer from vision impairment or blindness, with a large proportion of cases being preventable or manageable through early diagnosis, highlighting the critical role of AI-driven screening software in modern eye care systems.
Based on disease type, the market is segmented into diabetic retinopathy, glaucoma, cataracts, retinal disorders, corneal disorders, age-related macular degeneration, and others. The diabetic retinopathy segment accounts for a substantial share of the ophthalmic AI-assisted diagnosis market due to the increasing global prevalence of diabetes and the rising need for regular retinal screening. Diabetic retinopathy is one of the leading causes of vision impairment and blindness among working-age populations, making early detection and continuous monitoring essential for preventing severe visual complications. This has significantly increased the adoption of AI-powered diagnostic tools capable of detecting retinal abnormalities at early stages with high accuracy, thereby improving patient outcomes and disease management. Global health data from organizations such as the International Diabetes Federation (IDF) indicates that hundreds of millions of people are currently living with diabetes worldwide, a figure that continues to rise steadily, further reinforcing the growing demand for AI-assisted diabetic retinopathy screening solutions.
Ophthalmic AI-assisted Diagnosis Market- Geographical Insights
North America holds a leading position in the ophthalmic AI-assisted diagnosis market, supported by its advanced healthcare infrastructure, high adoption of digital health technologies, and strong investments in artificial intelligence and ophthalmic imaging innovation. AI-powered screening solutions for conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration are widely deployed across hospitals, specialty eye clinics, and teleophthalmology programs. In addition, strong disease prevalence further reinforces the need for early diagnosis and continuous monitoring. According to the U.S. Centers for Disease Control and Prevention (CDC), more than 38 million people in the United States are living with diabetes, highlighting the critical demand for routine retinal screening and timely detection of diabetes-related eye complications.
Europe is also experiencing steady growth in the ophthalmic AI-assisted diagnosis market, driven by increasing awareness of early eye disease detection, a rapidly aging population, and growing adoption of AI-based clinical decision-support systems. Healthcare providers across the region are investing in advanced retinal imaging technologies and next-generation AI platforms capable of integrating and analyzing multiple data sources, including OCT scans, fundus images, and electronic health records, to enhance diagnostic accuracy and workflow efficiency. A key trend in the region is the rising collaboration between healthcare institutions, research organizations, and technology companies to develop and deploy innovative AI-driven ophthalmic diagnostic solutions, further strengthening the region’s capabilities in advanced eye care.
Germany Ophthalmic AI-assisted Diagnosis Market- Key Insights
Germany is one of the leading markets for ophthalmic AI-assisted diagnosis in Europe, supported by its advanced healthcare infrastructure, strong medical technology industry, and continuous investments in healthcare digital transformation. Market growth is being driven by the rising prevalence of age-related vision disorders, diabetes-related retinal complications, and a rapidly aging population that requires frequent eye examinations and long-term disease monitoring.
Healthcare providers, ophthalmology clinics, and diagnostic centers across Germany are increasingly adopting AI-enabled retinal imaging systems and optical coherence tomography (OCT)-based diagnostic platforms to improve diagnostic accuracy, enhance workflow efficiency, and enable earlier detection of ocular diseases. In addition, Germany’s strong ecosystem of academic hospitals, research institutions, and healthcare technology companies is actively supporting the development, clinical validation, and commercialization of advanced AI-driven ophthalmic solutions. According to global public health estimates from the World Health Organization (WHO), more than 2.2 billion people worldwide are affected by vision impairment or blindness, with at least 1 billion cases being preventable or yet to be addressed. This global burden highlights the growing importance of early screening and advanced diagnostic technologies such as AI-assisted ophthalmic systems, further supporting market expansion in countries like Germany.
Ophthalmic AI-assisted Diagnosis Market- Competitive Landscape:
The ophthalmic AI-assisted diagnosis market is highly competitive, with participation from leading ophthalmic device manufacturers, healthcare technology companies, artificial intelligence specialists, and emerging digital health startups. Market players are investing heavily in advanced AI systems capable of accurately interpreting retinal images, optical coherence tomography (OCT) scans, visual field tests, and other ophthalmic data. The focus is increasingly on improving diagnostic accuracy, expanding the range of detectable eye disorders, securing regulatory approvals, and seamlessly integrating AI-based solutions into routine clinical workflows. In addition, companies are prioritizing workflow optimization, early disease detection, and scalable diagnostic platforms that support both in-clinic and remote eye care delivery. Strategic collaborations among ophthalmic equipment manufacturers, healthcare providers, research institutions, and AI software developers are further accelerating innovation and commercialization in this market. For instance, Digital Diagnostics developed the autonomous AI system IDx-DR, which received regulatory approval for diabetic retinopathy detection, highlighting the growing clinical acceptance of AI-based ophthalmic screening solutions.
Recent Developments
- In 2025, Carl Zeiss Meditec expanded its AI-enabled ophthalmology portfolio with the ZEISS Research Data Platform, a cloud-based system designed to support ophthalmic research and enable data-driven diagnostic innovation through the integration of multi-source clinical and research data for advanced AI analytics.
- In 2025, Topcon Healthcare strengthened its AI-driven ophthalmology capabilities through the acquisition of RetInSight, a company specializing in AI-based retinal imaging solutions. This acquisition enhanced Topcon’s OCT analysis capabilities, enabling improved detection and monitoring of retinal diseases such as neovascular age-related macular degeneration, diabetic macular edema, and retinal vascular disorders.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET KEY PLAYERS
- Topcon Healthcare
- Carl Zeiss Meditec
- Heidelberg Engineering
- Digital Diagnostics
- Eyenuk
- Optomed
- NIDEK Co., Ltd.
- Canon Medical Systems
- Altris AI
- AEYE Health
- Canon, Inc.
- Essilor Instruments
- RetInSight
- Kowa Company Ltd.
- Optos
- Others
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033
- Software
- AI Diagnostic Software
- Clinical Support System
- Others
- Services
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2020-2033
- Diabetic retinopathy
- Glaucoma
- Cataracts
- Retina disorders
- Corneal disorders
- Age-related macular degeneration
- Others
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033
- Machine Learning
- Computer Vision
- Natural Language Processing (NLP)
- Others
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY END USER- MARKET ANALYSIS, 2020-2033
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic & Imaging Centers
- Academic Research
- Others
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Ophthalmic AI-assisted Diagnosis Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Ophthalmic AI-assisted Diagnosis Market Snippet by Component
2.1.2. Ophthalmic AI-assisted Diagnosis Market Snippet by Disease Type
2.1.3. Ophthalmic AI-assisted Diagnosis Market Snippet by Technology
2.1.4. Ophthalmic AI-assisted Diagnosis Market Snippet by End User
2.1.5. Ophthalmic AI-assisted Diagnosis Market Snippet by Country
2.1.6. Ophthalmic AI-assisted Diagnosis Market Snippet by Region
2.2. Competitive Insights
3. Ophthalmic AI-assisted Diagnosis Key Market Trends
3.1. Ophthalmic AI-assisted Diagnosis Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Ophthalmic AI-assisted Diagnosis Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Ophthalmic AI-assisted Diagnosis Market Opportunities
3.4. Ophthalmic AI-assisted Diagnosis Market Future Trends
4. Ophthalmic AI-assisted Diagnosis Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Ophthalmic AI-assisted Diagnosis Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Ophthalmic AI-assisted Diagnosis Market Landscape
6.1. Ophthalmic AI-assisted Diagnosis Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Ophthalmic AI-assisted Diagnosis Market – By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
7.1.2. Software
7.1.2.1. AI Diagnostic Software
7.1.2.2. Clinical Support System
7.1.2.3. Others
7.1.3. Services
8. Ophthalmic AI-assisted Diagnosis Market – By Disease Type
8.1. Overview
8.1.1. Segment Share Analysis, By Disease Type, 2025 & 2033 (%)
8.1.2. Diabetic retinopathy
8.1.3. Glaucoma
8.1.4. Cataracts
8.1.5. Retina disorders
8.1.6. Corneal disorders
8.1.7. Age-related macular degeneration
8.1.8. Others
9. Ophthalmic AI-assisted Diagnosis Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
9.1.2. Machine Learning
9.1.3. Computer Vision
9.1.4. Natural Language Processing (NLP)
9.1.5. Others
10. Ophthalmic AI-assisted Diagnosis Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Disease Type, 2025 & 2033 (%)
10.1.2. Hospitals
10.1.3. Ambulatory Surgical Centers
10.1.4. Diagnostic & Imaging Centers
10.1.5. Academic Research
10.1.6. Others
11. Ophthalmic AI-assisted Diagnosis Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Ophthalmic AI-assisted Diagnosis Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Ophthalmic AI-assisted Diagnosis Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Ophthalmic AI-assisted Diagnosis Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Ophthalmic AI-assisted Diagnosis Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Ophthalmic AI-assisted Diagnosis Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Disease Type, 2020 - 2033 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Ophthalmic AI-assisted Diagnosis Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Topcon Healthcare
12.2.2. Carl Zeiss Meditec
12.2.3. Heidelberg Engineering
12.2.4. Digital Diagnostics
12.2.5. Eyenuk
12.2.6. Optomed
12.2.7. NIDEK Co., Ltd.
12.2.8. Canon Medical Systems
12.2.9. Altris AI
12.2.10. AEYE Health
12.2.11. Canon, Inc.
12.2.12. Essilor Instruments
12.2.13. RetInSight
12.2.14. Kowa Company Ltd.
12.2.15. Optos
12.2.16. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET KEY PLAYERS
- Topcon Healthcare
- Carl Zeiss Meditec
- Heidelberg Engineering
- Digital Diagnostics
- Eyenuk
- Optomed
- NIDEK Co., Ltd.
- Canon Medical Systems
- Altris AI
- AEYE Health
- Canon, Inc.
- Essilor Instruments
- RetInSight
- Kowa Company Ltd.
- Optos
- Others
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033
- Software
- AI Diagnostic Software
- Clinical Support System
- Others
- Services
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2020-2033
- Diabetic retinopathy
- Glaucoma
- Cataracts
- Retina disorders
- Corneal disorders
- Age-related macular degeneration
- Others
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033
- Machine Learning
- Computer Vision
- Natural Language Processing (NLP)
- Others
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY END USER- MARKET ANALYSIS, 2020-2033
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic & Imaging Centers
- Academic Research
- Others
GLOBAL OPHTHALMIC AI-ASSISTED DIAGNOSIS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
